Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

SELL
$0.31 - $6.32 $1,890 - $38,545
-6,099 Reduced 98.39%
100 $0
Q2 2022

Aug 03, 2022

BUY
$0.74 - $2.29 $4,513 - $13,966
6,099 Added 6099.0%
6,199 $7,000
Q1 2022

May 02, 2022

BUY
$1.96 - $2.96 $196 - $296
100 New
100 $0

Others Institutions Holding BNTC

About Benitec Biopharma Inc.


  • Ticker BNTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,809,500
  • Market Cap $271M
  • Description
  • Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...
More about BNTC
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.